Delivery Order SPE2DB20D3304-SPE2DB24FW6F0

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,077.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONCERTA ER 18 MG TABLET 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. The contract is not designated as a set-aside award....
This federal contract award, valued at $1,185.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 23, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $21,790.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). This is a firm fixed-price delivery order contract with an ultimate completion date of October 18, 2023. AmerisourceBergen holds a larger...
This federal contract award, valued at $10,050.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,367,180 units of CONCERTA ER 18 MG TABLET 100S, a medication commonly used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of June 29, 2023....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,189.73 delivery order contract is for the supply of CONCERTA ER TABS 27MG, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract is a firm fixed-price, delivery order type, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,747.04 firm fixed-price delivery order is for the supply of CONCERTA ER 18 MG TABLET 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 20, 2024 and was awarded on December 19, 2024. This award is a part of Amerisourcebergen's...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,229.48 firm-fixed-price delivery order is for the supply of 100 units of CONCERTA ER 18 MG TABLET, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). This contract is a part of Amerisourcebergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,747.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a completion date of December 17, 2024. The contract was not set aside for any specific business type....
This federal contract award, valued at $22,995.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36mg Concerta ER Tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,598.97 fixed-price delivery order is for the supply of CONCERTA ER 18 MG TABLET 100S, a medication used to treat ADHD. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW6F0
    Delivery Order

This federal contract award, valued at $11,954.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CONCERTA ER 18 MG tablets, a medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has a firm fixed price and an ultimate completion date of May 30, 2024. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:54 AM